INTRODUCTION
Inturned (INTU) is a tissue-specific planar cell polarity (PCP) effector. It mediates the polarity cues set up by the core PCP components in Drosophila and vertebrate animals. 1 During vertebrate morphogenesis, INTU also exerts prominent functions in primary cilia formation. Disrupting the Intu gene in mice can cause defects in neural tube formation, limb patterning, and hair follicle morphogenesis, all of which are associated with impaired cilia formation or function. [2] [3] [4] [5] [6] Mechanistically, INTU forms a molecular module with the other two PCP effectors, Fuzzy (FUZ) and WDPCP, to facilitate the assembly of intraflagellar transport A peripheral proteins into the intraflagellar transport A complex to facilitate cilia formation during vertebrate morphogenesis. 7 Because of their prominent functions in PCP and ciliogenesis, these PCP effectors are recognized as cilia and planar polarity effectors (CPLANEs). However, their roles in tissue homeostasis are unclear.
Basal cell carcinoma (BCC) of the skin is the most common malignancy in the United States, with more than 2.8 million new diagnoses annually. BCC originates from epidermal keratinocytes and is caused predominantly by loss-of-function mutations in the patched 1 (PTCH1) 8, 9 or gain-of-function mutations in the smoothened (SMO) gene, 10 which encodes upstream transmembrane components of the hedgehog (Hh) signaling pathway. Oncogenic mutations in PTCH1 or SMO ultimately lead to uncontrolled activation of the glioma-associated oncogene (Gli) transcription factors, thus, the Hh signaling pathway. 11 The activation of the Hh signaling pathway is dependent on the primary cilium, a cellular organelle that is essential for the translocation of Hh pathway components and the subsequent activation of the Hh target genes, such as Gli1 and Ptch1. 12, 13 The functional importance of primary cilia for the Hh signaling pathway is well-established during both morphogenesis [13] [14] [15] and the formation of Hh-dependent tumors, such as medulloblastoma 16 and BCC. 17 To gain insight into the function of the cilia and planar polarity effectors during mammalian tissue homeostasis, we explored the functions of INTU in the context of BCC formation. We found that the INTU gene is aberrantly upregulated in human BCC specimens and that genetically ablating the endogenous Intu in a BCC mouse model blocked BCC formation, likely upstream of the activation of Gli transcription factors. These observations suggest that INTU, which is essential for ciliogenesis, plays a permissive role during the development of BCC.
RESULTS

INTU is upregulated in human BCC
To determine whether INTU is involved in epidermal homeostasis, we constructed a tissue microarray (TMA) comprised of healthy human skin, BCC and squamous cell carcinoma (SCC) specimens (Supplementary Figure 1a) , and examined the transcriptional levels of the endogenous INTU gene by in situ hybridization. In healthy adult epidermis, INTU is predominantly expressed in interfollicular and follicular epidermal keratinocytes at a relatively modest level in comparison to embryonic skin (Figures 1a and b and Supplementary Figure 1b) . Strikingly, INTU expression was markedly elevated in BCC tumors (n = 19, P o0.05), but not in SCCs (n = 3), when compared to healthy adult skins (n = 3) (Figures 1a and b) . As expected, the transcriptional level of PTCH1, an Hh responsive genes, was also significantly elevated in BCC (P o 0.001), but not SCC, a type of keratinocyte carcinoma that is not dependent on Hh signaling (Figures 1a and c) . GLI1, another Hh-responsive gene, exhibited a similar trend (Figures 1a and d ). In contrast, the level of SMO, which is not an Hh responsive gene, was unchanged (Figures 1a and e) . Moreover, the relative expression levels of INTU correlated with that of PTCH1 (Spearman r = 0.784, Po0.001) or GLI1 (Spearman r = 0.858, P o 0.001), but not with SMO (Supplementary Figures 2a-c) , suggesting that elevated level of INTU is associated with activation of the Hh signaling pathway in human skin.
Human BCCs comprise abundant ciliated keratinocytes It was reported that the primary cilia were frequently observed in BCC. 17 To determine the prevalence of ciliated cells in human BCC, we evaluated the abundance of primary cilia in the same cohort of Figure 1 . INTU, Hh signaling, and primary cilia in healthy skin, BCC and SCC. (a) Representative hematoxylin and eosin staining and in situ hybridization of INTU, PTCH1, GLI1 and SMO in healthy adult human skin (normal skin), BCC and SCC. (b-e) Normalized scores of signal intensity of in situ hybridization in (a). (f) Representative images of primary cilia (ARL13B, green) and basal body (γ-TUB, red) in normal skin, BCC and SCC. Nuclei were stained with DAPI (blue). Lower panels are enlarged boxed areas above. (g) Percentage of ciliated keratinocytes in specimens in (f). n = 3 for normal adult skin or SCC, n = 19 for BCC. *Po 0.05; ***Po 0.001, two-way ANOVA and pair-wise post test. Scale bar = 25 μm.
human skin specimens described above by immunofluorescence labeling. A significantly increased proportion (38.5 ± 13.3%) of BCC cells possesses a primary cilium in comparison to keratinocytes (2.5 ± 2.2%) in healthy skins or SCCs (2.4 ± 0.6%) (Figures 1f and g, P o0.001), suggesting that the primary cilium may be a biomarker for BCC. Moreover, the abundance of ciliated cells also appeared correlated with the relative expression levels of INTU (Spearman r = 0.668, P o 0.001, Supplementary Figure 2d ). This observation suggested that the ciliogenic program is likely upregulated in BCC cells, which may be related to the elevated levels of INTU and the activated Hh signaling pathway.
Intu is essential for BCC formation INTU is essential for primary cilia formation and the activation of the Hh signaling pathway during skin morphogenesis. 6 (Figures 2a and b) , thus, the control mice had to be euthanized. Histologically, dorsal skins of control mice revealed remarkable downward growth of hyperplastic keratinocytes (Figure 2b ). Consistent with previous reports, [17] [18] [19] these cells exhibited features of human BCC, such as basaloid appearance, high nuclear to cytoplasmic ratio and palisading nuclei (Supplementary Figure 3a) . Immunofluorescence labeling confirmed that these cells coexpressed KRT14 and KRT17 (Supplementary Figure 3b) , which is characteristic of BCC. Moreover, these BCC-like cells were positive for yellow fluorescence protein (YFP, Figure 2c , upper and middle panels), which was coexpressed with SmoM2 as a fusion protein, thereby confirming that they were indeed derived from cells expressing SmoM2. Overall, these BCC-like lesions were reminiscent of human BCC. In situ hybridization confirmed that the endogenous Intu is abundantly expressed in these lesions (Figure 2c ).
In contrast, littermates homozygous for the conditional allele of Intu (Krt14-Cre ERT ;SmoM2 cond ;Intu flox/flox ) did not show gross signs of BCC formation even by 22 weeks (or 154 days) after tamoxifen induction (Figures 2a and b upper panels) . Thus, disease-free survival of these mutant mice homozygous for Intu was significantly different than that of the control littermates (Logrank test P o 0.0001, Figure 2a) . Histologically, the dorsal skins of homozygous mice exhibited rather mild hyperplasia and focal dysplasia ( Figure 2b , lower panels, arrow). YFP and KRT14 staining confirmed that keratinocytes of these mice expressed oncogenic SmoM2 (Figure 2c Intu is required for primary cilia formation in BCC Primary cilia are abundant in human BCC (Figures 1f and g ) and are essential for Hh signaling. Therefore, it was speculated that cells in the BCC-like lesions in control mice are likely to be ciliated. Indeed, BCC-like lesions in Krt14-Cre ERT ;SmoM2 cond ;Intu +/flox mice contained abundant ciliated keratinocytes (34.9 ± 6.7%, Figure 3a) , at a proportion similar to what was observed in human BCC (38.5 ± 13.3%, Figure 1g ). These findings not only suggest that the SmoM2 mouse models are able to recapitulate cellular features of human BCC, but also suggest that upregulated cilia formation is an intrinsic feature of BCC.
Given the essential role of INTU in ciliogenesis, particularly in epidermal keratinocytes, 6 we postulated that disrupting Intu might block BCC formation through impairing ciliogenesis. Indeed, homozygous Intu mutants (Krt14-Cre ERT ;SmoM2 cond ;Intu flox/flox ) contained few ciliated epidermal keratinocytes (8.8 ± 1.4%), reminiscent of those not expressing SmoM2 (9.4 ± 1.1%, Krt14-Cre ERT ;Intu +/ flox , Figure 3a ). These observations suggested that Intu might be required for BCC formation through facilitating ciliogenesis. Figure 4a) . Quantification of the transcriptional levels of Intu confirmed that the attenuated induction of Gli1 was indeed associated with diminished levels of Intu (Figure 4a ). These findings suggest that Intu is required for keratinocyte to active the Hh signaling pathway in response to the expression of oncogenic SmoM2.
To determine whether the Hh phenotype of Intu-deficient keratinocytes is corroborated with impaired ciliogenesis, we examined the primary cilia by immunofluorescence. In 4-OH tamoxifen-activated control cells (Krt14-Cre ERT ;SmoM2 cond ;Intu +/flox , left, indicated by *), SmoM2 was activated as demonstrated by YFP. Primary cilium was readily detectable in 49.9 ± 2.8% control cells (Figures 4b and c) . Moreover, SmoM2 appeared enriched at the primary cilium such that triple fluorescence labeling makes the cilium appear white ( In summary, these in vitro experiments suggested that Intu is a key component of both ciliogenesis and the SmoM2-activated oncogenic Hh signaling.
Intu acts upstream of the Gli transcription factors Data obtained so far in BCC was in line with prior findings that Intu is required for Hh pathway activation at the level of primary cilia. To examine whether Intu is also involved in the activation of the Hh signaling downstream of primary cilia, we examined Hh pathway in mouse embryonic fibroblasts (MEFs) that readily form primary cilia after serum starvation and respond to Hh pathway activation. First, we found that Intu − / − MEFs exhibited strong primary cilia phenotypes such that ciliogenesis was almost completely suppressed (0.52 ± 0.53%) when compared with wild type (WT) MEFs (61.2 ± 1.9%; Po 0.001, Figure 5a) . Moreover, the Smo agonist (SAG)-mediated Hh pathway activation was severely attenuated in Intu − / − MEFs in comparison to control WT MEFs, as determined by the processing of full-length GLI3 to GLI3 repressor (Figure 5b) , as well as the transcription levels of Gli1 and Ptch1 (Figures 5c and d, columns indicated by V) . These results suggest that Intu is required for Smo-mediated Hh pathway activation.
To determine whether Intu is also involved in the molecular signaling machinery downstream of Smo, we used plasmids expressing inactive full-length Gli2 (Gli2-FL) and a constitutively active Gli2 (Gli2_Δ1-413 or Gli2ΔN) to rescue the Hh pathway in To further determine whether elevated INTU levels might be sufficient to drive ciliogenesis and Hh pathway activation, we overexpressed mouse Intu that was fused with GFP (mIntu) 5 in WT MEFs. Intu was robustly overexpressed in MEFs (Figures 5f and g ), but ciliogenesis was not increased (Figure 5f) . Similarly, the level of endogenous Hh target genes, such as Ptch1, was also not increased ( Figure 5h ). These data do not support INTU as a driver for ciliogenesis or Hh pathway activation. Thus, the elevated expression of INTU in human BCCs might be required but not sufficient for the development of tumors.
DISCUSSION
The ciliogenic functions of the CPLANE genes (Fuz, Wdpcp and Intu) are indispensable during vertebrate morphogenesis. [4] [5] [6] [20] [21] [22] [23] [24] [25] The current study extended their biological functions to mammalian tumorigenesis by demonstrating that INTU plays a permissive role in BCC formation through regulating primary cilia formation and Hh signaling. Because that the cilia and planar polarity effectors form a molecular module by interacting physically to facilitate the assembly of the intraflagellar transport A complex during ciliogenesis, 7 it is speculated that genetically disrupting other CPLANE genes may block BCC formation in a fashion similar to Intu.
The robust upregulation of INTU transcription in BCC cells was surprising. It is not only in concert with the idea that INTU is prerequisite for ciliogenesis, but also suggests that INTU is required for the propagation and maintenance of ciliated BCC cells. While we did not obtain evidence supporting a role of INTU in directly driving ciliogenesis or Hh signaling (Figures 5g and h) , it is of interest to know that the expression level of INTU correlates with those of Hh responsive genes and ciliogenesis in BCC specimens (Supplementary Figure 3) . These observations suggest that INTU acts in concert with other molecular events to promote ciliogenesis and Hh pathway activation in BCC.
It remains unknown how INTU is upregulated in BCC. It may be a mere reflection of the increased proportion of ciliated BCC cells that already express relatively high endogenous levels of INTU. It is also possible that the expression of oncogenic mutant Hh genes, such as PTCH1, SMO or Gli2, may drive de novo upregulation of INTU, and probably other ciliogenic genes, to deregulate the ciliogenic and retraction programs to favor cilia formation in keratinocytes. Another possible mechanism is UV, a primary risk factor for BCC 26 and a robust inducer of ciliogenesis. 27 UV may exert previously unappreciated ciliogenic functions during the early stages of BCC formation. Understanding how INTU is upregulated may provide important insight into BCC tumorigenesis.
Previous observations suggested that very few interfollicular epidermal keratinocytes in adult skin possess a functional cilium, whereas BCC cells are frequently ciliated. 6, 17, 28 Indeed, quantifications obtained in this study confirmed these findings, thereby suggest that primary cilium is a candidate biomarker for BCC. But it is unclear how BCC cells acquired the cilia phenotype. In addition to the altered intrinsic ciliogenic programs discussed above, it is also possible that BCC originates from the few ciliated keratinocytes. It is conceivable that ciliated keratinocytes can activate the Hh signaling pathway more readily upon acquiring Hh pathway mutations, thereby, may gain growth advantage over unciliated keratinocytes. Thus, these findings provided insight into the debated origin of BCC 18, 19, [29] [30] [31] [32] by suggesting that BCC may be more readily established from ciliated keratinocytes in the skin and hair follicles. Collectively, evidence supports the idea that ciliated keratinocytes are prone, whereas unciliated keratinocytes are resistant, to malignant transformation of keratinocytes.
Activation of the Hh pathway, which is a major driver of BCC, is dependent upon the primary cilium. The primary cilium is critical for BCC formation as we and others demonstrated that preventing cilia assembly by genetically ablating ciliogenic genes, such as Ift88, Kif3a and Intu prevented BCC (Wong et al., 17 and this study) could block the development of BCC in mice. These findings suggest that ciliogenic proteins might be therapeutic targets for BCC. However, systemically targeting INTU and other ciliogenic proteins is likely to result in significant adverse effects on the normal ciliary functions, such as those in the retina, kidney and other organs. Therefore, this strategy is unlikely worthwhile. In contrast, targeting SMO with small molecules is remarkably effective for locally advanced or metastatic BCCs. 33 However, the development of treatment-resistant tumors in association with SMO inhibitor treatment [34] [35] [36] [37] presses for the identification of new therapeutic targets along the Hh signaling pathway. 38, 39 Thus, targeting Hh signaling components downstream of ciliogenesis and SMO may become promising therapeutic strategies for BCC and other Hh-dependent cancers. [40] [41] [42] In summary, this study provided evidence that ciliogenic genes, such as INTU, are dynamically regulated in the skin, and that the upregulation of INTU is required but not sufficient for ciliogenesis and oncogenic Hh signaling during BCC formation. Understanding the molecular mechanism underlying with the aberrant upregulation of ciliogenic genes, such as INTU, during early stages of BCC formation may shed light on the prevention of BCC and other Hhdependent tumors.
MATERIALS AND METHODS
Skin and BCC specimens
Formalin-fixed and paraffin-embedded healthy adult human skin, BCC and SCC specimens (n = 25) were obtained from the biobank of the Department of Pathology. All specimens were de-identified. The use of human specimens was approved by the Institutional Review Board of Stony Brook University. Tumor histology was confirmed and areas of interest were chosen by two pathologists (CL and KRS) before they were used for the construction of a TMA. Two cores of each specimen were randomly placed in the TMA block. All the staining and analyses were performed using slides sectioned from the TMA. One BCC specimen was lost during this process and was excluded. The TMA was comprised of three healthy skins, 19 BCCs and three SCCs. Cond ) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Mice were bred to generate the bigenic or trigenic mice used in the study. Littermates were used as controls wherever possible. Both male and female mice were included in this study, and housed in groups of the same age and sex regardless of genotypes. Cre recombination was induced by tamoxifen (T5648, Sigma-Aldrich, St Louis, MO, USA) as described previously. 18 Briefly, 2.5 mg tamoxifen (dissolved in sesame oil) was injected intraperitoneally to 22-27-day-old mice once daily for 5 days. BrdU labeling was performed by injecting 10 μg per gram of body weight of BrdU labeling reagent (Life Technologies, Waltham, MA, USA) 2 h prior to euthanasia. Injections were carried out blindly.
Based on our experience gained from a pilot study, we collected skin specimens from mice at two time points after tamoxifen induction. Additional time points were applied on Intu-deficient (Krt14-Cre ERT ; SmoM2 cond ;Intu flox/flox ) mice up to 22 weeks after induction. We aimed to obtain a minimum of three mice for each time point. Freshly dissected dorsal skins were either frozen in optimal cutting temperature compound (Sakura Finetek USA, Torrance, CA, USA) or fixed overnight in 10% buffered formalin and processed for routine histology. All procedures related to mice were approved by the IACUC of Stony Brook University.
Measuring the thickness of the epidermis
Three randomly chosen fields of each hematoxylin and eosin section were photographed with a 20 × objectives, and the thickness of the interfollicular epidermis was measured using Nikon (Melville, NY, USA) NISElements Analysis D software. The average epidermal thickness from each mouse was used for analysis. Specifically, n = 9 or 18 for Krt14-Cre 
Cell culture and in vitro assays
The isolation of primary mouse epidermal keratinocyte was conducted as described elsewhere. 43 Briefly, skins of E18.5 embryos were digested by dispase II (Roche, Indianapolis, IN, USA) to separate epidermis and dermis. Epidermis was then digested briefly with trypsin (Invitrogen) to dissociate keratinocytes. Keratinocytes were suspended in defined keratinocyte serum-free medium (Gibco, Life Technologies Waltham, MA, USA) and plated on collagen I-coated tissue culture plates (Thermo Fisher, Waltham, MA, USA). MEFs were cultured with Dulbecco's modified Eagle's medium (4.5 g/l glucose) supplemented with 10% fetal bovine serum and 100 U/ml penicillin and 100 U/ml streptomycin (Gibco, Life Technologies). To induce Cre recombination, subconfluent keratinocytes were treated with 0.5 μM 4-OH tamoxifen (Sigma-Aldrich) for 5 h before grown to nearconfluent, and starved in medium without growth supplement for 72 h before harvested for RNA extraction or immunofluorescence. To activate Hh signaling, MEFs were grown to confluency and serum-starved in medium containing 0.25% serum for 24 h, then treated with 400 nM SMO agonist (SAG, Calbiochem, San Diego, CA, USA) for 4.5 h before harvested for mRNA extraction. 
DNA constructs and transfection
Expression plasmid encoding Intu, full length mouse Gli2 (Gli2-FL), and the constitutively active Gli2 lacking the coding sequence for the first 413 amino acids (Gli2ΔN) were described previously. 5, 44 GLI2 was expressed as a fusion protein with YFP. The transfections were carried out by Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA) per manufacturer's instructions.
Quantitative RT-PCR
RNA isolation and quantitative RT-PCR analyses were performed as previously described. 6 The following TaqMan probes were used: Ptch1, Mm00436026_m1; Gli1, Mm00494645_m1; Gli2, Mm01293111_m1; Intu, Mm01284303_m1; and β-actin, Mm00607939_m1 (Life Technologies). Results were analyzed using the ΔΔCt method. Relative expression levels of target genes were normalized with β-actin and compared with controls.
In situ hybridization and scoring
In situ hybridization was carried out on formalin-fixed paraffin embedded tissue sections using the RNAScope system (Advanced Cell Diagnostic, Inc, Hayward, CA, USA) per manufacturer's instructions. The probes used are INTU (413571), GLI1 (310991), PTCH1 (405781), SMO (405831), Intu (413601), Gli1 (311001) and Ptch1 (402811).
Semi-quantitative scoring was performed for signaling generated by each target probe on all TMA specimens. Scoring was based on the average number of signal puncta within a cell's boundary. POLR2A (Cat 310451) was used as an internal positive control for the quality of each specimen for this assay. Scores of each target probe were then normalized by POLR2A. Normalized scores of the randomly placed cores of the same specimen were averaged and presented. Scoring was performed by the investigators blind to the protocol.
